中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2014年
27期
13-14
,共2页
苏士奎%朱晓彤%马肃%张成立%祁春雷%杜海歌
囌士奎%硃曉彤%馬肅%張成立%祁春雷%杜海歌
소사규%주효동%마숙%장성립%기춘뢰%두해가
老年%急性ST段抬高心肌梗死%替罗非班%心肌再灌注%左心功能
老年%急性ST段抬高心肌梗死%替囉非班%心肌再灌註%左心功能
노년%급성ST단태고심기경사%체라비반%심기재관주%좌심공능
Elderly patients%Acute ST-segment elevation myocardial infarction%Tirofiban%Myocardial reperfusion%Left ventricular function
目的:探讨替罗非班对老年急性ST段抬高心肌梗死患者的心肌再灌注与左心功能的影响。方法112例老年急性ST段抬高心肌梗死患者按照随机数字法分为对照组和研究组,均给予经皮冠状动脉介入治疗,对照组术中给予常规治疗,研究组术中给予替罗非班治疗,观察其对心肌再灌注与左心功能的影响。结果研究组心肌再灌注发生率明显高于对照组,两组比较差异有统计学意义(P<0.05)。研究组的左室射血分数(LVEF)明显高于对照组,差异有统计学意义(P<0.05)。结论老年急性ST段抬高心肌梗死患者在经皮冠状动脉介入治疗过程中应用替罗非班是可行的,改善患者的心肌再灌注和心功能,值得临床应用。
目的:探討替囉非班對老年急性ST段抬高心肌梗死患者的心肌再灌註與左心功能的影響。方法112例老年急性ST段抬高心肌梗死患者按照隨機數字法分為對照組和研究組,均給予經皮冠狀動脈介入治療,對照組術中給予常規治療,研究組術中給予替囉非班治療,觀察其對心肌再灌註與左心功能的影響。結果研究組心肌再灌註髮生率明顯高于對照組,兩組比較差異有統計學意義(P<0.05)。研究組的左室射血分數(LVEF)明顯高于對照組,差異有統計學意義(P<0.05)。結論老年急性ST段抬高心肌梗死患者在經皮冠狀動脈介入治療過程中應用替囉非班是可行的,改善患者的心肌再灌註和心功能,值得臨床應用。
목적:탐토체라비반대노년급성ST단태고심기경사환자적심기재관주여좌심공능적영향。방법112례노년급성ST단태고심기경사환자안조수궤수자법분위대조조화연구조,균급여경피관상동맥개입치료,대조조술중급여상규치료,연구조술중급여체라비반치료,관찰기대심기재관주여좌심공능적영향。결과연구조심기재관주발생솔명현고우대조조,량조비교차이유통계학의의(P<0.05)。연구조적좌실사혈분수(LVEF)명현고우대조조,차이유통계학의의(P<0.05)。결론노년급성ST단태고심기경사환자재경피관상동맥개입치료과정중응용체라비반시가행적,개선환자적심기재관주화심공능,치득림상응용。
Objective To investigate the influence of tirofiban on myocardial reperfusion and left ventricular function of elderly patients with acute ST-segment elevation myocardial infarction. Methods A total of 112 elderly patients with acute ST-segment elevation myocardial infarction were randomly divided into control group and study group according to Random number method. After given percutaneous coronary intervention, patients in the control group received conventional therapy, while patients in the study group were given tirofiban treatment. The influence of tirofiban on myocardial reperfusion and left ventricular function was observed. Results The incidence of myocardial reperfusion in the study group was significantly higher than that of the control group. Difference between the two groups was statistically significant (P<0.05). Left ventricular ejection fraction (LVEF) values of the study group was significantly higher than that of the control group, and the difference was statistically significant (P<0.05). Conclusion Tirofiban applied in elderly patients of acute ST-segment elevation myocardial infarction patients with percutaneous coronary intervention is feasible, and it can improve myocardial reperfusion and heart function. It is worthy of clinical application.